CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 3
Author(s): Salvatore Cuzzocrea
Affiliation:
Export Options
About this article
Cite this article as:
Cuzzocrea Salvatore , Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2019; 18 (3) . https://dx.doi.org/10.2174/187152731803190307123835
DOI https://dx.doi.org/10.2174/187152731803190307123835 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enhanced Detection of Characteristic Vibration Signal of Generator Based on Self-Adapted Multi-Scale Top-Hat Transformation
Recent Advances in Electrical & Electronic Engineering Potential Novel Anxiolytic Drugs
Current Pharmaceutical Design Changes in E-Selectin Levels Predict Carotid Stenosis Progression after Carotid Artery Stenting
Current Neurovascular Research A Salicylic Acid-Based Analogue Discovered from Virtual Screening as a Potent Inhibitor of Human 20α-Hydroxysteroid Dehydrogenase
Medicinal Chemistry The Opioid Receptor Independent Actions of Kappa Receptor Agonists in the Cardiovascular System
Current Pharmaceutical Design Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Unusual DNA Conformations: Implications for Telomeres
Current Medicinal Chemistry - Anti-Cancer Agents Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors
Current Alzheimer Research Exposure of Aggregation-Prone Segments is the Requirement for Amyloid Fibril Formation
Current Protein & Peptide Science An Update on GABA Analogs for CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued) Perispinal Etanercept for Treatment of Alzheimers Disease
Current Alzheimer Research Processing of Cholinesterase-like α/β-Hydrolase Fold Proteins: Alterations Associated with Congenital Disorders
Protein & Peptide Letters Nicotine Vaccines
CNS & Neurological Disorders - Drug Targets An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging
Current Pharmaceutical Design Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Towards a Mature Discipline of Pharmacogenomics: Epistemological Reflections
Current Pharmacogenomics and Personalized Medicine BST-2 Expression in Human Hepatocytes is Inducible by All Three Types of Interferons and Restricts Production of Hepatitis C Virus
Current Molecular Medicine Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
Current Respiratory Medicine Reviews Biochemical, Biomedical and Metabolic Aspects of Imidazole-Containing Dipeptides with the Inherent Complexity to Neurodegenerative Diseases and Various States of Mental Well-Being: A Challenging Correction and Neurotherapeutic Pharmaceutical Biotechnology for Treating Cognitive Deficits, Depression and Intellectual Disabilities
Current Pharmaceutical Biotechnology